Todd Hulgan

4.2k total citations · 1 hit paper
100 papers, 3.0k citations indexed

About

Todd Hulgan is a scholar working on Virology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Todd Hulgan has authored 100 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Virology, 59 papers in Infectious Diseases and 53 papers in Emergency Medicine. Recurrent topics in Todd Hulgan's work include HIV Research and Treatment (61 papers), HIV-related health complications and treatments (51 papers) and HIV/AIDS drug development and treatment (36 papers). Todd Hulgan is often cited by papers focused on HIV Research and Treatment (61 papers), HIV-related health complications and treatments (51 papers) and HIV/AIDS drug development and treatment (36 papers). Todd Hulgan collaborates with scholars based in United States, Canada and Australia. Todd Hulgan's co-authors include David W. Haas, Timothy R. Sterling, Peter F. Rebeiro, Stephen Raffanti, John R. Koethe, David B. Clifford, Megan Turner, Asha Kallianpur, Bryan E. Shepherd and Roy M. Gulick and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Todd Hulgan

98 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy

2019 224 citations Peter F. Rebeiro, Megan Turner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd Hulgan United States	28	1.7k	1.3k	1.2k	620	243	100	3.0k
Ramin Ebrahimi United States	34	1.4k 0.9×	497 0.4×	448 0.4×	1.3k 2.1×	146 0.6×	164	5.5k
David A. Leaf United States	33	1.3k 0.8×	572 0.4×	1.7k 1.5×	949 1.5×	200 0.8×	75	3.9k
Brookie M. Best United States	37	1.9k 1.1×	807 0.6×	698 0.6×	532 0.9×	213 0.9×	129	4.2k
John Milberg United States	19	822 0.5×	215 0.2×	527 0.4×	1.3k 2.1×	264 1.1×	27	3.7k
Paolo Bonfanti Italy	26	1.2k 0.7×	500 0.4×	884 0.7×	437 0.7×	64 0.3×	140	2.3k
Vicente Estrada Spain	28	1.5k 0.9×	1.1k 0.9×	1.0k 0.9×	509 0.8×	588 2.4×	113	2.6k
Yechiel A. Hekster Netherlands	29	753 0.4×	481 0.4×	155 0.1×	257 0.4×	175 0.7×	73	2.7k
Heather J. Ribaudo United States	34	3.2k 1.9×	2.4k 1.8×	1.6k 1.4×	658 1.1×	204 0.8×	112	4.4k
Tamsin A. Knox United States	25	752 0.4×	308 0.2×	875 0.7×	648 1.0×	130 0.5×	53	2.3k
John R. Koethe United States	32	2.0k 1.2×	1.1k 0.8×	2.4k 2.0×	655 1.1×	217 0.9×	140	3.6k

Countries citing papers authored by Todd Hulgan

Since Specialization

Citations

This map shows the geographic impact of Todd Hulgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Hulgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Hulgan more than expected).

Fields of papers citing papers by Todd Hulgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Hulgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Hulgan. The network helps show where Todd Hulgan may publish in the future.

Co-authorship network of co-authors of Todd Hulgan

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Hulgan. A scholar is included among the top collaborators of Todd Hulgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Hulgan. Todd Hulgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kundu, Suman, David C. Samuels, Samuel Bailin, et al.. (2025). Mitochondrial DNA Haplogroups, Biomarkers of Inflammation and Immune Activation, and Risk of Diabetes in Veterans With and Without Human Immunodeficiency Virus. The Journal of Infectious Diseases. 232(6). e1003–e1011.

Kaur, Harpreet, David Alvarez-Carbonell, VIJAY NAGAMPALLI, et al.. (2023). Contemporary Antiretroviral Therapy Dysregulates Iron Transport and Augments Mitochondrial Dysfunction in HIV-Infected Human Microglia and Neural-Lineage Cells. International Journal of Molecular Sciences. 24(15). 12242–12242. 8 indexed citations

Kaur, Harpreet, William S. Bush, Scott Letendre, et al.. (2021). Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIV. Molecular Neurobiology. 58(10). 4842–4855. 3 indexed citations

Kaur, Harpreet, Asha Kallianpur, Todd Hulgan, et al.. (2021). A Haptoglobin Exon Copy Number Variant Associates With HIV-Associated Neurocognitive Impairment in European and African-Descent Populations. Frontiers in Genetics. 12. 756685–756685. 1 indexed citations

Kallianpur, Asha, Wanqing Wen, Angelika Erwin, et al.. (2020). Higher iron stores and the HFE 187C>G variant delay onset of peripheral neuropathy during combination antiretroviral therapy. PLoS ONE. 15(10). e0239758–e0239758. 3 indexed citations

Ellis, Ronald J., David J. Moore, Erin E. Sundermann, et al.. (2020). Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV. Neurology Neuroimmunology & Neuroinflammation. 7(6). 7 indexed citations

Erlandson, Kristine M., Yuki Bradford, David C. Samuels, et al.. (2019). Mitochondrial DNA Haplogroups and Frailty in Adults Living with HIV. AIDS Research and Human Retroviruses. 36(3). 214–219. 8 indexed citations

Kallianpur, Asha, Mariana Gerschenson, Todd Hulgan, et al.. (2018). Hemochromatosis ( HFE ) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy. AIDS Research and Human Retroviruses. 34(11). 942–949. 4 indexed citations

Samuels, David C., Asha Kallianpur, Ronald J. Ellis, et al.. (2017). European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection. SHILAP Revista de lepidopterología. 1(2). 330–330. 5 indexed citations

10.

Kipp, Aaron M., Peter F. Rebeiro, Bryan E. Shepherd, et al.. (2017). Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care. AIDS and Behavior. 21(7). 1996–2004. 32 indexed citations

11.

Koethe, John R., Aihua Bian, Ayumi Shintani, et al.. (2013). Circulating Interleukin-6, Soluble CD14, and Other Inflammation Biomarker Levels Differ Between Obese and Nonobese HIV-Infected Adults on Antiretroviral Therapy. AIDS Research and Human Retroviruses. 29(7). 1019–1025. 36 indexed citations

12.

Lake, Jordan E., Grace A. McComsey, Todd Hulgan, et al.. (2012). A Randomized Trial of Raltegravir Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor in HIV-Infected Women with Lipohypertrophy. AIDS Patient Care and STDs. 26(9). 532–540. 27 indexed citations

13.

Koethe, John R., et al.. (2011). Serum Leptin Level Mediates the Association of Body Composition and Serum C-Reactive Protein in HIV-Infected Persons on Antiretroviral Therapy. AIDS Research and Human Retroviruses. 28(6). 552–557. 9 indexed citations

14.

Samuels, David C., Gregory K. Robbins, Jeffrey A. Canter, et al.. (2011). Mitochondrial Genomics and CD4 T-Cell Count Recovery After Antiretroviral Therapy Initiation in AIDS Clinical Trials Group Study 384. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(4). 363–370. 17 indexed citations

15.

Canter, Jeffrey A., Gregory K. Robbins, David B. Clifford, et al.. (2010). African Mitochondrial DNA Subhaplogroups and Peripheral Neuropathy during Antiretroviral Therapy. The Journal of Infectious Diseases. 201(11). 1703–1707. 29 indexed citations

16.

Shepherd, Bryan E., Cathy A. Jenkins, Samuel E. Stinnette, et al.. (2010). Postpartum Discontinuation of Antiretroviral Therapy and Risk of Maternal AIDS-Defining Events, Non-AIDS–Defining Events, and Mortality Among a Cohort of HIV-1–Infected Women in the United States. AIDS Patient Care and STDs. 24(5). 279–286. 13 indexed citations

17.

Shepherd, Bryan E., Todd Hulgan, Peter F. Rebeiro, et al.. (2009). Race and Sex Differences in Antiretroviral Therapy Use and Mortality among HIV‐Infected Persons in Care. The Journal of Infectious Diseases. 199(7). 991–998. 89 indexed citations

18.

Hulgan, Todd, John P. Donahue, Laura Smeaton, et al.. (2009). Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors. European Journal of Clinical Pharmacology. 65(11). 1081–1088. 3 indexed citations

19.

Hulgan, Todd, et al.. (2005). Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons.. PubMed. 38(3). 277–82. 15 indexed citations

20.

Hulgan, Todd, David W. Haas, Jonathan L. Haines, et al.. (2005). Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS. 19(13). 1341–1349. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact